Jose T. Stefano

Av. Dr Arnaldo, 455, 3° Andar, #3115, 1246903
Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Extracellular vesicles and microRNAs in metabolic dysfunction-associated steatotic liver disease: from steatosis to hepatocellular carcinoma.

Extracellular vesicles and microRNAs in metabolic dysfunction-associated steatotic liver disease: from steatosis to hepatocellular carcinoma.

Journal: EXCLI journal

Published: July 02, 2025

Polymorphism's MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD.

Polymorphism's MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD.

Journal: International journal of molecular sciences

Published: May 22, 2025

The impact of the PNPLA3 rs738406 C>G polymorphism on hepatocellular carcinoma risk in Brazilian patients with chronic hepatitis C and advanced fibrosis.

The impact of the PNPLA3 rs738406 C>G polymorphism on hepatocellular carcinoma risk in Brazilian patients with chronic hepatitis C and advanced fibrosis.

Journal: Clinics (Sao Paulo, Brazil)

Published: May 06, 2025

Low testosterone is associated with steatosis in the male population with spinal cord injury.

Low testosterone is associated with steatosis in the male population with spinal cord injury.

Journal: Archives of endocrinology and metabolism

Published: April 11, 2025

Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study.

Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study.

Journal: Clinics (Sao Paulo, Brazil)

Published: December 16, 2024

ASSOCIATION BETWEEN ANXIETY AND DEPRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD).

ASSOCIATION BETWEEN ANXIETY AND DEPRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD).

Journal: Arquivos de gastroenterologia

Published: September 05, 2023

PRECLINICAL MODELS OF LIVER CÂNCER.

PRECLINICAL MODELS OF LIVER CÂNCER.

Journal: Arquivos de gastroenterologia

Published: April 06, 2023

P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC.

P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC.

Journal: Journal of molecular histology

Published: January 31, 2023

PNPLA3 GENE POLYMORPHISM AND RED MEAT CONSUMPTION INCREASED FIBROSIS RISK IN NASH BIOPSY-PROVEN PATIENTS UNDER MEDICAL FOLLOW-UP IN A TERTIARY CENTER IN SOUTHWEST BRAZIL.

PNPLA3 GENE POLYMORPHISM AND RED MEAT CONSUMPTION INCREASED FIBROSIS RISK IN NASH BIOPSY-PROVEN PATIENTS UNDER MEDICAL FOLLOW-UP IN A TERTIARY CENTER IN SOUTHWEST BRAZIL.

Journal: Arquivos de gastroenterologia

Published: November 01, 2022

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features.

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features.

Journal: Biomedicines

Published: September 21, 2022

Non-pharmacological management options for MAFLD: a practical guide.

Non-pharmacological management options for MAFLD: a practical guide.

Journal: Therapeutic advances in endocrinology and metabolism

Published: August 06, 2022

Synbiotic Supplementation Modulates Gut Microbiota, Regulates β-Catenin Expression and Prevents Weight Gain in ob/ob Mice: Preliminary Findings.

Synbiotic Supplementation Modulates Gut Microbiota, Regulates β-Catenin Expression and Prevents Weight Gain in ob/ob Mice: Preliminary Findings.

Journal: International journal of molecular sciences

Published: July 19, 2022

Showing 1-12 of 49

Last Updated: 09/26/2026